Infection Surveillance Solutions Market to Reach US$ 763.7 Million at CAGR of 13.0% by 2025

Infection Surveillance Solutions Market to 2025 - Global Analysis and Forecasts By Type (Software and Services), End User (Hospitals, Nursing Homes, and Other End Users) and Geography

Publication Month : Feb 2019

  • Report Code : TIPHE100001413
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 183
Inquire Before Buy

PRICING

$4550

$2730

The Infection Surveillance Solutions market was valued at US$ 294.1 million in 2017 and it is projected to reach US$ 763.7 million by 2025; it is expected to grow at a CAGR of 13.7% from 2018 to 2025.

Infection surveillance solutions refer to the software and integrated entities that helps to gather the medical data related to factors causing healthcare associated infections (HAIs) in the medical facilities and offer features in order to monitor, analyze, control as well as create a control action plan to reduce and prevent the HAIs. The growth of the Infection Surveillance Solutions market is attributed to the increasing number of healthcare associated infections, government initiatives for prevention of healthcare associated infections (HAIs), rise in the integration of information technology into various healthcare platforms are key drivers for the growth of the market. However, the growth of the market is restrained by various factors such as high costs of the software and dearth of skilled professionals to offer services in remote areas.

The Infection Surveillance Solutions market is expected to witness substantial growth post-pandemic. The Infection Surveillance Solutions market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Infection Surveillance Solutions Market



Lucrative Regions for Infection Surveillance Solutions in Healthcare Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Growing Applications of Infection Surveillance Solutions in Healthcare to Drive Infection Surveillance Solutions Market Growth

Healthcare associated infections, or nosocomial infections affects the patients in hospitals and other healthcare facilities that are not present in the patients at the time of admission. These infections affect the patients not only during their stay in the hospitals, but also post patient’s discharge from hospitals. Moreover, these occupational infections are observed to be common in within the hospital and nursing staff too. According to the World Health Organization (WHO), hundreds of millions of patients are affected by healthcare associated infections every year leading to significant morbidity and mortality around the world. The WHO Healthcare Associated Infections Fact Sheet of 2016 suggests that of every 100 hospitalized patients at a given time, 7 in the developed countries and 10 in developing countries acquires at least one healthcare associated infection.

Moreover, in high income countries, approximately 30% of patients in intensive care units (ICUs) are affected by at least one HAIs. This rate of HAIs is approximately 2-3 folds higher in the low and middle income countries. In addition, the WHO claims that the newborns are at a higher risk of developing these infections, with infection rates 3-20 times higher in developing countries as compared to high income countries of the globe. As a result of this significant prevalence rate of these infections, the endemic burden of health care associated infections is also turning up higher, majorly among the developing economies of the world. The European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. The Centre estimates that 4 131 000 patients are affected by approximately 4 544 100 episodes of health care-associated infection every year in Europe. Thus, the increasing prevalence of HAIs is expected to create a demand for infection surveillance solutions promoting market growth across the world.

The healthcare associated infections acts as a major threat to patient safety, affecting one out of every 25 hospital patients at a given point, according to Agency for Healthcare Research & Quality. These infections are significantly increasing the economic burden of the healthcare system among all the countries worldwide. The government and healthcare departments of the high as well medium to low income countries are developing action plans and undertaking several initiatives to reduce this burden as well as prevent the mortality rates occurring as a result of hospital acquired infections or nosocomial infections. 

The prevention and reduction of healthcare-associated infections is a top priority for the U.S. Department of Health and Human Services (HHS). The HHS Steering Committee for the Prevention of Healthcare-Associated Infections was established in July 2008. The Steering Committee, along with scientists and program officials across HHS, developed the HHS Action Plan to prevent Healthcare-Associated Infections, providing a roadmap for HAI prevention in acute care hospitals. 

Moreover, the US Department of Health & Human Services have employed Agency for Healthcare Research and Quality that funds various works in the US to help the frontline clinicians and other healthcare staff to prevent HAIs by improving safety and care delivery to the patients. Not only in the North America and European high-income countries, major economies in Asia Pacific including Japan China and India are also significantly working to develop surveillance programs and promote the use of monitoring software for the prevention of these infections. For instance, Japan Healthcare System employed active surveillance, hand hygiene promotion, isolation cohort of resistant microorganism and bundle care for HAI prevention in various healthcare facilities. Additionally, the Australian Commission on Safety and Quality in Healthcare developed a Healthcare Associated Infection (HAI) Prevention Program aims to build on facility and jurisdictional initiatives to develop a national approach to reducing HAI by identifying and addressing systemic problems and gaps, and ensuring comprehensive actions are undertaken in a nationally coordinated way by leaders and decision makers in both public and private health care sectors. Thus, various government initiatives to reduce healthcare associated infections by adaption of advanced techniques such as surveillance software are expected to propel the growth of the global infection surveillance solutions market over the forecast yearsOver the years, technology has improved the way healthcare providers treat and take care of the patients. There have been a number of ways in which these changes in the healthcare systems are incorporated. The major one of these changes includes intersection of advanced healthcare and information technology. Health IT is often considered to be a silent partner in healthcare, which is not evidently noticed, however plays a crucial part of the system. The growing ageing population and rise in costly chronic care needs are exerting considerable demands on our health systems. Governments are expected to do more in the face of healthcare funding challenges and skilled labor shortage. As computer and technology use in hospitals, clinics and private practice expands, information technology is being used in countless ways to improve healthcare delivery, patient safety, and the relationship between patients and healthcare providers.

Surveillance of healthcare associated infections is of prime importance in prevention of infections. The methods and practices for surveillance have evolved as technology becomes more advanced. The availability of electronic surveillance software (ESS) has increased, and yet adoption of ESS is slow. The infection control software offers way to rebalance the time by monitoring several data feeds, alerting infection prevention, simplifying reporting, tracking trends graphically as well as improving outbreak identification. Due to the advantages offered by these software systems, government is investing significantly to promote the innovation in healthcare IT based systems. For instance, in 2017, the US health IT investment total whopped to US$ 7.1 billion. Thus, massive adoption of IT based platforms in healthcare is expected to support the growth of infection surveillance solutions market over the forecast years.

Type-Based Insights

In terms of type, the Infection Surveillance Solutions market is segmented into software and services. In 2017, the software segment held a largest market share of 62.5% of the infection surveillance solutions market, by technology.

Infection Surveillance Solutions Market, by Type – 2017 and 2025



Infection Surveillance Solutions in Healthcare Market, by Type – 2017 and 2025
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

End User-Based Insights

In terms of end user, the Infection Surveillance Solutions market is segmented into hospitals, nursing homes, and other end users. The hospitals segment is anticipated to grow at a CAGR of 12.8% during the forecast period. The high prevalence of the hospital associated infection across the world is likely to enforce the healthcare setting for the adoption of these solutions in their infrastructure to prevent the healthcare associated infections.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Infection Surveillance Solutions Market: Strategic Insights

infection-surveillance-solution-market
Market Size Value inUS$ 294.1 Million in 2017
Market Size Value byUS$ 763.7 Million by 2025
Growth rateCAGR of 13.7% from 2018-2025
Forecast Period2018-2025
Base Year2018
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The Infection Surveillance Solutions market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Infection Surveillance Solutions Market – by Type

  • Software

o Web-Based Software

o On-Premises Software

  • Services  

o Implementation Services

 o Support and Maintenance Services

  • o Training and Consulting Services

Infection Surveillance Solutions Market – by End User

  • Hospitals
  • Nursing Homes
  • Others

Infection Surveillance Solutions Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • BD
  • Wolters Kluwer
  • Sunquest Information Systems, Inc.
  • Premier
  • Baxter (ICNet Systems, Inc.)
  • GOJO Industries, Inc.
  • Cerner Corporation
  • Deb Group Ltd.
  • VigiLanz Corporation
  •  PeraHealth
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type , End User and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

The List Of Companies

  1. BD
  2. Wolters Kluwer
  3. Sunquest Information Systems, Inc.
  4. Premier
  5. Baxter
  6. GOJO Industries, Inc.
  7. Cerner Corporation
  8. Deb Group Ltd.
  9. PeraHealth
  10. VigiLanz Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Infection Surveillance Solutions Market